Neuroone Medical Technologies Corp expected to post a loss of 23 cents a share - Earnings Preview

Neuroone Medical Technologies

07/12/2021 11:01

* Neuroone Medical Technologies Corp  NMTC.OQ   NMTC.O  is
expected to report results on December 9.
* The Eden Prairie Minnesota-based  company is expected to
report revenue of $50 thousand, according to the mean estimate
from 2 analysts, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for Neuroone Medical
Technologies Corp is for a loss of 23 cents per share. 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
​
* Wall Street's median 12-month price target for Neuroone
Medical Technologies Corp is $5.88​, about 61.5% above​ its last
closing price of $2.26. ​​​
This summary was machine generated December 7 at 11:00 GMT.  All
figures in US dollars  unless otherwise stated